Truncated chemokines lacking an N-terminal region that activate CCR1 and/or FPRL1 and compositions containing the truncated chemokines are provided. Methods of identifying agents that modulate CCR1 and/or FPRL1 activity either by modulating the production of the truncated chemokines or the ability of the truncated chemokines to activate CCR1 and/or FPRL1 are also disclosed. Methods using the truncated chemokines to inhibit or activate CCR1 and/or FPRL1 mediated biological activities are also disclosed.

 
Web www.patentalert.com

< Metalloprotease activation of myostatin, and methods of modulating myostatin activity

> Polynucleotides encoding novel PCSK9 variants

> Detection, characterization and treatment of viral infection and methods thereof

~ 00536